Stay updated with breaking news from Nasdaq Alvr. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
AlloVir, Inc. (NASDAQ:ALVR – Get Free Report) has been assigned a consensus rating of “Reduce” from the six brokerages that are currently covering the firm, Marketbeat.com reports. Two investment analysts have rated the stock with a sell recommendation, three have given a hold recommendation and one has assigned a buy recommendation to the company. The […]
NEW YORK, Feb. 17, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of AlloVir, Inc....
NEW YORK, Feb. 10, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of AlloVir, Inc....
Shares of AlloVir, Inc. (NASDAQ:ALVR – Get Free Report) have received an average recommendation of “Reduce” from the six brokerages that are currently covering the company, Marketbeat Ratings reports. Two investment analysts have rated the stock with a sell rating, three have assigned a hold rating and one has assigned a buy rating to the […]
Shares of AlloVir, Inc. (NASDAQ:ALVR – Get Free Report) have earned a consensus rating of “Reduce” from the six analysts that are covering the company, Marketbeat Ratings reports. Two equities research analysts have rated the stock with a sell recommendation, three have issued a hold recommendation and one has given a buy recommendation to the […]